() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Tissue Culture

Asterion Lodges Operational Works Permit Application for Development at its Medicinal Cannabis Propagation and Processing Facility

Asterion Cannabis Inc. (“Asterion” or the “Company”) announces that the Company’s wholly-owned Australian subsidiary (“Asterion Australia”) has submitted its Operational Works permit (the “Operational Works Permit”) application to the Toowoomba Regional Council (the “Council”) to seek approval of certain development activities at the Company’s Toowoomba Medicinal Cannabis project (the “Project”), as part of the final approval process for development of the Project.
Read more

Pharmagreen’s Tissue Culture Revenue Model

Pharmagreen is currently working on supply contracts with licensed growers.  The current price for clone starter plantlets offered only by a handful of licensed producers is CDN $15 per clone or higher.  Pharmagreen plans to sell its superior tissue cultured starter plantlets for CDN $8 or more thereby providing superior quality plantlets at a reasonable price point to all licensed growers.  With a planned production of over 10 million plantlets annually and a selling price of CDN $8 or more each, Pharmagreen’s revenue model from tissue culture sales can reach up to CDN $80 Million or more on an annual basis.   The direct costs of production per plantlet is approximately CDN $1 dollar, thereby generating a potential gross profit margin of CDN $70 Million or more annually.  Per square foot of production space, Pharmagreen revenue model is poised to be one of the highest profit margins as compared to other ACMPR (Access to Cannabis for Medical Purposes Regulations) licensed producers in Canada.
Read more